Rehman Medical Institue
Peshawar, Khyber Pakhtunkhwa, 092, Pakistan
Not Yet Recruiting
NCT Number: NCT07015788
Open -Label,Cross Over Trail Evaluating the Glycemic Impact of Peach Varieties in Healthy Adullts
This study aims to evaluate the effect of different peach varieties on the glycemic index (GI) in healthy adult participants. While peaches are generally classified as low-GI fruits, variations in sugar composition, fiber content, and ripeness among different cultivars may influence their glycemic response. By assessing and comparing the GI values of several commonly consumed peach varieties, this trial seeks to provide more precise dietary recommendations for glycemic control and support better fruit selection for individuals managing blood glucose levels.
Not Yet Recruiting
Trial opening soon.
Get NotifiedKey information
Conditions
Age range
18 year–50 year
Sex eligibility
All sexes
Study type
Interventional
Phase
Not applicable
Primary location
About this study
This study aims to evaluate the effect of different peach varieties on the glycemic index (GI) in healthy adult participants. While peaches are generally classified as low-GI fruits, variations in sugar composition, fiber content, and ripeness among different cultivars may influence their glycemic response. By assessing and comparing the GI values of several commonly consumed peach varieties, this trial seeks to provide more precise dietary recommendations for glycemic control and support better fruit selection for individuals managing blood glucose levels.
Who can participate
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
• Healthy male and female adults aged 18-50 years
- BMI between 18.5-24.9 kg/m²
- Normal fasting blood glucose (<100 mg/dL)
- Willingness to adhere to the study protocol Exclusion Criteria:• Diagnosed diabetes, metabolic syndrome, or any glucose metabolism disorder
- Use of medications or supplements that affect glucose levels
- Allergy to peaches or intolerance to test/reference foods
- Pregnant or breastfeeding women
- Smoking or use of recreational drugs
Treatment and study plan
EARLY GRAND
OtherParticipants will consume a standardized portion of peach variety A containing 50 grams of available carbohydrates. Capillary blood glucose levels will be measured at multiple time points post-consumption to assess glycemic response.
SPRING CREST PEACH
OtherParticipants will consume a standardized portion of peach variety B containing 50 grams of available carbohydrates. Capillary blood glucose levels will be measured at multiple time points post-consumption to assess glycemic response.
INDIAN BLOOD
OtherParticipants will consume a standardized portion of peach variety C containing 50 grams of available carbohydrates. Capillary blood glucose levels will be measured at multiple time points post-consumption to assess glycemic response.
Primary outcomes
-
Glycemic Index
Time frame: 2 hours post-consumption (per intervention)
Participants will consume a standardized portion of a peach variety containing 50 grams of available carbohydrates. Capillary blood glucose levels will be measured at multiple time points post-consumption to assess glycemic response.
Secondary outcomes
-
Incremental Area Under the Curve (iAUC) for Blood Glucose
Time frame: 0-120 minutes post-consumption
The iAUC will be calculated for each intervention using the trapezoidal method, excluding values below baseline. This helps quantify the glycemic response.
-
Peak Blood Glucose Concentration
Time frame: 0-120 minutes post-consumption
The highest recorded blood glucose concentration during the 2-hour postprandial period following consumption of each intervention.
Study contacts
Contact information is provided by the study sponsor or research team.
Sponsors and collaborators
Lead sponsor
Rehman Medical Institute - RMI
Other
Registry information
Important dates
- Study start
- 2025
- Primary completion
- 2025
- Study completion
- 2025
- First posted
- Jun 11, 2025
- Registry last updated
- Jun 11, 2025
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.